A Double-Blind, Placebo-Controlled, Ascending-Dose, Randomized Study to Evaluate the Safety, Tolerability and Effects on Cognition of AL-108 after 12 Weeks of Intranasal Administration in Subjects with Mild Cognitive Impairment
Year: 2013
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
DOI: 10.1159/000348347
Authors: Bruce H. Morimoto, Don Schmechel, Joe Hirman, Andrew Blackwell, Julian Keith, Michael Gold, on behalf of the AL-108-211 Study Investigators
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2084247881